Doximity (DOCS) – Investment Analysts’ Weekly Ratings Updates

Several analysts have recently updated their ratings and price targets for Doximity (NASDAQ: DOCS):

• 2/10/2025 – Doximity had its price target raised by analysts at Mizuho from $55.00 to $65.00. They now have a “neutral” rating on the stock.
• 2/10/2025 – Doximity had its price target raised by analysts at The Goldman Sachs Group, Inc. from $58.00 to $80.00. They now have a “neutral” rating on the stock.
• 2/7/2025 – Doximity was upgraded by analysts at Leerink Partnrs from a “hold” rating to a “strong-buy” rating.
• 2/7/2025 – Doximity was upgraded by analysts at Piper Sandler from a “neutral” rating to an “overweight” rating. They now have a $78.00 price target on the stock, up previously from $31.00.
• 2/7/2025 – Doximity had its “outperform” rating reaffirmed by analysts at Raymond James. They now have a $83.00 price target on the stock, up previously from $65.00.
• 2/7/2025 – Doximity was upgraded by analysts at Leerink Partners from a “market perform” rating to an “outperform” rating. They now have a $90.00 price target on the stock, up previously from $60.00.
• 2/7/2025 – Doximity had its price target raised by analysts at Canaccord Genuity Group Inc. from $60.00 to $71.00. They now have a “hold” rating on the stock.
• 2/7/2025 – Doximity had its price target raised by analysts at Wells Fargo & Company from $43.00 to $55.00. They now have an “equal weight” rating on the stock.
• 2/7/2025 – Doximity had its price target raised by analysts at Needham & Company LLC from $65.00 to $82.00. They now have a “buy” rating on the stock.
• 1/13/2025 – Doximity had its price target raised by analysts at Wells Fargo & Company from $41.00 to $43.00. They now have an “equal weight” rating on the stock.
• 1/8/2025 – Doximity had its price target lowered by analysts at KeyCorp from $70.00 to $65.00. They now have an “overweight” rating on the stock.
• 1/6/2025 – Doximity had its price target raised by analysts at Bank of America Co. from $54.00 to $57.00. They now have a “neutral” rating on the stock.
• 12/20/2024 – Doximity is now covered by analysts at Stephens. They set an “equal weight” rating and a $55.00 price target on the stock.

Doximity Stock Up 0.1 %

DOCS opened at $75.05 on Thursday. The firm has a market cap of $14.01 billion, a price-to-earnings ratio of 75.05, a price-to-earnings-growth ratio of 4.61 and a beta of 1.39. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $85.21. The business’s 50 day moving average is $57.03 and its two-hundred day moving average is $46.83.

Insiders Place Their Bets

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the transaction, the director now directly owns 6,360 shares in the company, valued at approximately $366,463.20. This trade represents a 75.87 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 37.40% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of DOCS. Sanctuary Advisors LLC purchased a new position in shares of Doximity in the 2nd quarter valued at approximately $270,000. GAMMA Investing LLC grew its stake in shares of Doximity by 40.1% in the 3rd quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock valued at $63,000 after purchasing an additional 412 shares during the last quarter. Creative Planning grew its stake in shares of Doximity by 13.7% in the 3rd quarter. Creative Planning now owns 22,104 shares of the company’s stock valued at $963,000 after purchasing an additional 2,671 shares during the last quarter. nVerses Capital LLC grew its stake in shares of Doximity by 67.5% in the 3rd quarter. nVerses Capital LLC now owns 12,900 shares of the company’s stock valued at $562,000 after purchasing an additional 5,200 shares during the last quarter. Finally, Bleakley Financial Group LLC purchased a new position in shares of Doximity in the 3rd quarter valued at approximately $213,000. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.